Publications by authors named "M Sanati"

Immune responses against tumor antigens play a role in confining tumor growth. In response, cancer cells developed several mechanisms to bypass or defeat these anti-tumor immune responses-collectively referred to as "tumor immune evasion". Recent studies have shown that a group of non-coding RNAs, namely circRNAs affect several aspects of tumor immune evasion through regulation of activity of CD8 + T cells, regulatory T cells, natural killer cells, cytokine-induced killer cells or other immune cells.

View Article and Find Full Text PDF
Article Synopsis
  • Chemoresistance is a major issue in cancer treatment, prompting the exploration of RNA interference (RNAi) as a potential gene therapy approach to enhance chemotherapy effectiveness.
  • Small-interfering RNA (siRNA) faces challenges in entering cancer cells due to biological barriers, but nanoparticles provide a solution by shielding siRNA and aiding its delivery.
  • The review highlights advancements in nanoparticle technology for siRNA delivery in cancer treatment, discusses existing obstacles, and considers future opportunities to combat chemoresistance in cancer therapy.
View Article and Find Full Text PDF

Doxorubicin is an anthracyline recognized as an antitumor antibiotic agent. It is widely used in the chemotherapeutic regimens in different types of cancers. Resistance to doxorubicin is a major clinical obstacle and main cause of failure in cancer chemotherapy.

View Article and Find Full Text PDF

Objectives: It has been shown that growth factors and small molecules play an essential role in the proliferation of β cells and insulin production. In this study, we investigated the effects of small molecules (WS6 and 5-iodotubercidin) and growth factors (TGFβ, HGF, and EGF) on the proliferation of β-like human ipSCs.

Methods: iPSCs derived β cells were treated with small molecules and growth factors.

View Article and Find Full Text PDF

Spinal cord injury (SCI) leaves a temporary or enduring motor, sensory, and autonomic function loss, significantly impacting the patient's quality of life. Given their biocompatibility, bioactivity, and tunable attributes, three-dimensional scaffolds frequently employ carbohydrates to facilitate spinal cord regeneration. These scaffolds have also been engineered to be novel local delivery platforms that present distinct advantages in the targeted transportation of drug candidates to the damaged spinal cord, ensuring the right dosage and duration of administration.

View Article and Find Full Text PDF